Product Information
LEVETIRACETAM 100 MG/ML SOLN is a generic product labeled by Major Pharmaceuticals, priced at $0.0301 per ML under NDC 00904742016. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Jul 15, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/mL
Manufacturer
Major PharmaceuticalsNDC
00904742016
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA214757FDA Approved
7/15/2022
TE Code
AA
On Market Since
7/16/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 100 MG/ML SOLN has been published 111 times since Aug 21, 2024, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per ML |
|---|---|
| All-time high | $0.0316 (Jan 14, 2026) |
| All-time low | $0.0248 (Nov 20, 2024) |
| 52-week high | $0.0316 |
| 52-week low | $0.0301 |
| Median price | $0.0306 |
| Average price | $0.0303 |
| Largest weekly change | -20.4% (Nov 20, 2024) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 100 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 100 MG/ML SOLN, manufactured by Major Pharmaceuticals, is $0.0301 per ML (NDC 00904742016), effective Sep 30, 2026.
How has the price of LEVETIRACETAM 100 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 100 MG/ML SOLN has declined 4.1%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 100 MG/ML SOLN?
Since Aug 21, 2024, the NADAC for LEVETIRACETAM 100 MG/ML SOLN has ranged from a low of $0.0248 (Nov 20, 2024) to a high of $0.0316 (Jan 14, 2026), with a median of $0.0306 per ML.
Are there cheaper alternatives to LEVETIRACETAM 100 MG/ML SOLN?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVETIRACETAM 100 MG/ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVETIRACETAM 100 MG/ML SOLN?
LEVETIRACETAM 100 MG/ML SOLN (NDC 00904742016) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.